Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial.
Kopetz S, Murphy DA, Pu J, Ciardiello F, Desai J, Van Cutsem E, Wasan HS, Yoshino T, Saffari H, Zhang X, Hamilton P, Xie T, Yaeger R, Tabernero J.
Kopetz S, et al. Among authors: zhang x.
Nat Med. 2024 Sep 23. doi: 10.1038/s41591-024-03235-9. Online ahead of print.
Nat Med. 2024.
PMID: 39313594